Gland Pharma Releases Audio Recording of Q2 and H1 FY27 Earnings Call
Earnings discussion held on November 6, 2026, audio webcast accessible via company website
Gland Pharma Limited announced the audio recording of its earnings call for the quarter and half year ended September 30, 2026, has been made available on its official website for investor access.
Gland Pharma Limited
Earnings Call Transcript
Gland Pharma Limited has uploaded the audio recording of its earnings call for the quarter and half year ended September 30, 2026, enabling investors to review the discussion held on November 6, 2026.
The earnings call took place on November 6, 2026, at 18:30 IST, focusing on the company’s financial performance and operational updates for Q2 and H1 of fiscal year 2027.
Investors and stakeholders can access the audio recording of this call through a direct weblink on Gland Pharma’s official website, facilitating transparent communication.
This release comes in continuation of prior disclosures made by the company dated October 21, 2026, reflecting ongoing investor engagement efforts.
Highlights
- Earnings call for Q2 and H1 FY27 held on November 6, 2026, at 18:30 IST.
- Audio recording is publicly available at https://glandpharma.com/images/Q2_FY27.mp3.
- Filing complies with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
- Provides investors detailed access to management discussion and performance insights.
Key Data Snapshot
What happened
- Gland Pharma conducted an earnings call discussing financials for Q2 and H1 FY27 on November 6, 2026.
- The company made the audio recording of this call publicly available on its website for investor reference.
Regulatory and governance context
- This disclosure follows requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- It supplements previous disclosures issued on October 21, 2026, offering continuity in investor communication.
Highlights
- Earnings call for Q2 and H1 FY27 held on November 6, 2026, at 18:30 IST.
- Audio recording is publicly available at https://glandpharma.com/images/Q2_FY27.mp3.
- Filing complies with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
- Provides investors detailed access to management discussion and performance insights.
Disclosures
- Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on Earnings Call Transcript
View allLatest corporate announcements and market updates in Earnings Call Transcript.
Sunrakshakk Industries India Limited Posts INR 265.17 Crores Revenue with 130% PAT Increase in Q2 FY27
Sunrakshakk Industries India Limited reported its Q2 FY27 financial results with revenue of INR 265.17 crores and a profit after tax of INR 16 crores, reflecting year-on-year growth of 119.20% in revenue and 130.10% in PAT, supported by expansion in its FMCG, FMCG intermediates, and edible segments.
Read Full StoryReligare Enterprises Posts INR 4,717 Crores Income and INR 145 Crores Loss After Tax in H1 FY27, Resumes Lending and Strengthens Board
Religare Enterprises Limited has reported consolidated total income of INR 4,717 crores and a loss after tax of INR 145 crores for the half-year ending September 30, 2026, marking a 19% increase in income year-on-year. The company is transitioning from preparation to execution phase by strengthening its board with RBI-approved promoter and shareholder directors, resuming lending through Religare Finvest, and advancing growth in its core financial services and insurance businesses.
Read Full StoryBlack Box Limited Posts Record Q2 FY27 Revenue of INR 1,936 Crores and Expands Order Backlog to $1.04 Billion
Black Box Limited reported its highest-ever quarterly revenue of INR 1,936 crores for Q2 FY27, marking a 22% year-on-year increase, alongside an 88% year-on-year growth in its order backlog, which reached $1.04 billion as of September 2026. Data center order bookings crossed $250 million during H1 FY27, signaling strong momentum in hyperscale digital infrastructure projects.
Read Full Story